These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 27237107)

  • 1. Reply to letter: Exogenous melatonin for Parkinson's disease: 'Waking up' to the need for further trials.
    Rodrigues TM; Castro Caldas A; Ferreira JJ
    Parkinsonism Relat Disord; 2016 Aug; 29():123-4. PubMed ID: 27237107
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacological interventions for daytime sleepiness and sleep disorders in Parkinson's disease: Systematic review and meta-analysis.
    Rodrigues TM; Castro Caldas A; Ferreira JJ
    Parkinsonism Relat Disord; 2016 Jun; 27():25-34. PubMed ID: 27010071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exogenous melatonin for Parkinson's disease: 'Waking up' to the need for further trials.
    Breen DP; Barker RA
    Parkinsonism Relat Disord; 2016 Aug; 29():121-2. PubMed ID: 27215394
    [No Abstract]   [Full Text] [Related]  

  • 4. [Sleep and wakefulness disorders in neurodegenerative diseases].
    Yakovleva OV; Poluektov MG; Levin OS; Lyashenko EA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(4. Vyp. 2):83-91. PubMed ID: 30059056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of exogenous melatonin on sleep and motor dysfunction in Parkinson's disease. A randomized, double blind, placebo-controlled study.
    Medeiros CA; Carvalhedo de Bruin PF; Lopes LA; Magalhães MC; de Lourdes Seabra M; de Bruin VM
    J Neurol; 2007 Apr; 254(4):459-64. PubMed ID: 17404779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of melatonin on sleep disorders in a monkey model of Parkinson's disease.
    Belaid H; Adrien J; Karachi C; Hirsch EC; François C
    Sleep Med; 2015 Oct; 16(10):1245-51. PubMed ID: 26429753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sleep disorders in Parkinson's disease without dementia: a comparative randomized controlled study of melatonin and clonazepam].
    Litvinenko IV; Krasakov IV; Tikhomirova OV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(12):26-30. PubMed ID: 23388588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive bizarreness in the dream and waking mentation of nonpsychotic patients with Parkinson's disease.
    D'Agostino A; De Gaspari D; Antonini A; Kantzas I; Limosani I; Manzone ML; Schiavella M; Paganini L; Siri C; Rizzi P; Scarone S
    J Neuropsychiatry Clin Neurosci; 2010; 22(4):395-400. PubMed ID: 21037124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progressive dopamine and hypocretin deficiencies in Parkinson's disease: is there an impact on sleep and wakefulness?
    Wienecke M; Werth E; Poryazova R; Baumann-Vogel H; Bassetti CL; Weller M; Waldvogel D; Storch A; Baumann CR
    J Sleep Res; 2012 Dec; 21(6):710-7. PubMed ID: 22747735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Early Stages of Parkinson's Disease: Comparative Characteristics of Sleep-Wakefulness Cycle in Patients and Model Animals].
    Kovalzon VM; Ugrumov MV; Pronina TS; Dorokhov VB; Manolov AI; Dolgikh VV; Ukraintseva YV; Moiseenko LS; Poluektov MG; Kalinkin AL
    Fiziol Cheloveka; 2015; 41(6):114-8. PubMed ID: 26859995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melatonin attenuates hLRRK2-induced sleep disturbances and synaptic dysfunction in a Drosophila model of Parkinson's disease.
    Sun X; Ran D; Zhao X; Huang Y; Long S; Liang F; Guo W; Nucifora FC; Gu H; Lu X; Chen L; Zeng J; Ross CA; Pei Z
    Mol Med Rep; 2016 May; 13(5):3936-44. PubMed ID: 26985725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Achieving 24-hour control of Parkinson's disease symptoms: use of objective measures to improve nocturnal disability.
    Chaudhuri KR; Pal S; Bridgman K; Trenkwalder C
    Eur Neurol; 2001; 46 Suppl 1():3-10. PubMed ID: 11741097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sleep attacks and dopamine agonists for Parkinson's disease: what is currently known?
    Zesiewicz TA; Hauser RA
    CNS Drugs; 2003; 17(8):593-600. PubMed ID: 12775195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of nocturnal hemodialysis on melatonin rhythm and sleep-wake behavior: an uncontrolled trial.
    Koch BC; Hagen EC; Nagtegaal JE; Boringa JB; Kerkhof GA; Ter Wee PM
    Am J Kidney Dis; 2009 Apr; 53(4):658-64. PubMed ID: 18950916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melatonin: role in gating nocturnal rise in sleep propensity.
    Lavie P
    J Biol Rhythms; 1997 Dec; 12(6):657-65. PubMed ID: 9406042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating the Efficacy of Nocturnal Continuous Subcutaneous Apomorphine Infusion in Sleep Disorders in Advanced Parkinson's Disease: The APO-NIGHT Study.
    Fernández-Pajarín G; Sesar Á; Ares B; Castro A
    J Parkinsons Dis; 2016 Oct; 6(4):787-792. PubMed ID: 27662329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sleep Dysfunction in Parkinson's Disease.
    Falup-Pecurariu C; Diaconu Ş
    Int Rev Neurobiol; 2017; 133():719-742. PubMed ID: 28802939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sleep-wake functions and quality of life in patients with subthalamic deep brain stimulation for Parkinson's disease.
    Bargiotas P; Eugster L; Oberholzer M; Debove I; Lachenmayer ML; Mathis J; Pollo C; Schüpbach WMM; Bassetti CL
    PLoS One; 2017; 12(12):e0190027. PubMed ID: 29253029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sleep disorders in patients with Parkinson's disease: epidemiology and management.
    Larsen JP; Tandberg E
    CNS Drugs; 2001; 15(4):267-75. PubMed ID: 11463132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Greater daytime sleepiness in subcortical stroke relative to Parkinson's disease and Alzheimer's disease.
    Bliwise DL; Rye DB; Dihenia B; Gurecki P
    J Geriatr Psychiatry Neurol; 2002; 15(2):61-7. PubMed ID: 12083594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.